CenterPoint Energy, Inc. (CNP) reported first-quarter 2025 adjusted earnings of 53 cents per share, which lagged the Zacks Consensus Estimate of 55 cents by 3.6%. The bottom line also missed the year-ago quarter’s figure of 55 cents. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)The year-over-year decline can be attributed to the unfavorable timing of recoveries from interim capital mechanisms, and partly due to dilution of common equity issuances.The company’s GAAP earnings were ...

Core Insights - Lam Research (LRCX) reported strong third-quarter fiscal 2025 results, with both revenue and earnings exceeding expectations [1][2] - The company provided an optimistic outlook for the fourth quarter of fiscal 2025, despite recent stock price declines due to broader tech market concerns [3] Financial Performance - LRCX's non-GAAP earnings for Q3 fiscal 2025 were $1.04 per share, beating the Zacks Consensus Estimate by 4%, and reflecting a 33.3% year-over-year increase [2] - Revenues for the same quarter reached $4.72 billion, surpassing the consensus estimate by 1.64% and marking a 24.5% increase from $3.79 billion in the previous year [2] Segment Performance - Systems revenues accounted for $3.04 billion, representing 64.3% of total revenues, which is a 15.6% increase from the previous quarter and a 26.6% increase year-over-year, although it fell short of the Zacks Consensus Estimate of $2.69 billion [4] - Customer Support Business Group revenues were $1.68 billion, making up 35.7% of total revenues, which is a 3.7% decrease from the previous quarter but a 20.5% increase year-over-year [4] Geographic Revenue Breakdown - In Q3, revenue contributions came from China (31%), Korea (24%), and Taiwan (24%), with Japan (10%), the United States (4%), Southeast Asia (4%), and Europe (3%) making up the remainder [5] Operating Metrics - Non-GAAP gross margin improved to 49.0%, up 150 basis points from the previous quarter, while non-GAAP operating margin rose to 32.8%, an increase of 210 basis points [6] - Non-GAAP operating expenses increased to $763 million, a 3.8% rise from $735 million in the prior quarter [6] Balance Sheet and Cash Flow - As of March 30, 2025, Lam Research held $5.46 billion in cash and cash equivalents, down from $5.67 billion [7] - Cash flow from operating activities significantly increased to $1.31 billion, up from $742 million in the previous quarter [7] - The company paid dividends totaling $295.7 million and repurchased shares worth $347 million during the quarter [7] Future Guidance - For Q4 fiscal 2025, Lam Research projects revenues of $5 billion (+/- $300 million), indicating a year-over-year growth of 17.23% compared to the Zacks Consensus Estimate of $4.54 billion [8] - The company expects a non-GAAP gross margin of 49.5% (+/-1%) and a non-GAAP operating margin of 33.5% (+/-1%) [9] - Projected non-GAAP earnings per share for Q4 are $1.20 (+/- $0.10), with a diluted share count of 1.28 billion, compared to the Zacks Consensus Estimate of 96 cents, reflecting an 18.5% year-over-year growth [9]

CNX Resources Corporation (CNX) reported first-quarter 2025 operating earnings of 78 cents per share, which beat the Zacks Consensus Estimate of 64 cents by 21.9%. The bottom line also increased 73.3% from 45 cents in the year-ago quarter. (See the Zacks Earnings Calendar to stay ahead of market-making news.)CNX’s RevenuesThe company reported revenues of $441 million, which missed the Zacks Consensus Estimate of $492 million by 10.4%. However, the top line increased 15.7% from the prior-year quarter’s $381 ...

2025.04.24 FIRST QUARTER EARNINGS CALL SAFE HARBOR Today's presentation includes forward-looking statements that reflect management's current expectations about the Company's future business and financial performance. These statements are subject to certain risks and uncertainties that could cause actual results to differ from anticipated results. Factors that could cause actual results to differ from anticipated results are identified in Item 1A of the Company's Form 10-K, and Item 1A of the most recent Qu ...

Core Viewpoint - Allegion plc reported strong first-quarter 2025 results, with adjusted earnings per share of $1.86, exceeding estimates and showing a 20% year-over-year increase [1] Revenue Details - Total revenues reached $941.9 million, a 5.4% increase year over year, surpassing the Zacks Consensus Estimate of $932 million [1][2] - Organic revenues grew by 4%, primarily driven by robust performance in the non-residential business in the Americas [1] - Acquired assets contributed 1.8% to revenue growth, while foreign exchange negatively impacted revenues by 3% [2] Segment Performance - Allegion Americas revenues increased by 6.8% year over year to $757.8 million, accounting for 80.5% of total revenues, exceeding estimates [2] - Organic revenues in this segment rose by 4.9%, supported by high-single-digit growth in non-residential businesses [2] - Allegion International revenues slightly declined by 0.3% year over year to $184.1 million, but organic revenues grew by 0.9% due to pricing [3] Margin Profile - Cost of revenues increased by 3.4% year over year to $519.4 million, while gross profit rose by 8% to $422.5 million, leading to a gross margin increase of 110 basis points to 44.9% [4] - Adjusted EBITDA grew by 12.2% year over year to $228.0 million, with a margin increase of 140 basis points to 24.2% [4] - Adjusted operating income increased by 14.1% year over year to $196.4 million, with an adjusted margin of 22.7%, up 150 basis points [5] Balance Sheet and Cash Flow - At the end of Q1 2025, Allegion had cash and cash equivalents of $494.5 million, down from $503.8 million at the end of 2024, while long-term debt slightly decreased to $1.97 billion [6] - The company generated net cash of $104.5 million from operating activities, more than doubling year over year, with available cash flow of $83.4 million [7] - Allegion repurchased shares worth $40.0 million and paid dividends totaling $43.6 million, reflecting a 3.6% year-over-year increase [7] 2025 Outlook - Allegion has reaffirmed its 2025 guidance, expecting revenue growth of 1-3% and organic revenue growth of 1.5-3.5% [9] - Adjusted earnings are projected to be between $7.65 and $7.85 per share, with available cash flow estimated at 85-90% of adjusted net income [9]

Core Viewpoint - Xcel Energy Inc. reported a decline in first-quarter 2025 operating earnings, missing consensus estimates due to increased operational costs and expenses [1][5]. Financial Performance - Operating earnings for Q1 2025 were 84 cents per share, down 4.5% from 88 cents in the same quarter last year [1][2]. - Total revenues reached $3.9 billion, slightly missing the consensus estimate of $3.92 billion but showing a 7.1% increase from $3.65 billion year-over-year [3]. - Operating income decreased by 2.9% year-over-year to $677 million [5]. Segment Performance - Electric segment revenues were $2.83 billion, up 5.6% from $2.68 billion in the prior year [4]. - Natural gas segment revenues increased by 12.1% to $1.05 billion from $0.94 billion year-over-year [4]. - Other revenues fell to $16 million from $23 million in the previous year [4]. Expense Analysis - Total operating expenses rose by 8.7% year-over-year to $3.23 billion, driven by higher electric fuel and purchased power costs, as well as increased operating and maintenance expenses [5]. - Interest charges and financing costs increased by 11.6% from $277 million to $309 million [6]. Customer Volume and Sales - Electric customer volume grew by 1.1%, while natural gas customer volume increased by 0.9% [6]. - Natural gas sales rose by 0.5%, and electric sales volume increased by 1.9% compared to the previous year [6]. Guidance and Future Outlook - Xcel Energy reaffirmed its 2025 earnings per share guidance in the range of $3.75-$3.85, with the consensus estimate at $3.81 [7]. - Retail electric sales are expected to increase by 3% in 2025, while natural gas sales volumes are anticipated to rise by 1% [7]. - The company plans to invest $45 billion from 2025 to 2029 to enhance its infrastructure [7]. Zacks Rank - Xcel Energy currently holds a Zacks Rank of 4 (Sell) [8].

Core Insights - Merck reported revenue of $15.53 billion for Q1 2025, a decrease of 1.6% year-over-year, with an EPS of $2.22, up from $2.07 in the same quarter last year, exceeding both revenue and EPS consensus estimates [1][2] Financial Performance - Revenue of $15.53 billion compared to Zacks Consensus Estimate of $15.39 billion, resulting in a surprise of +0.93% [1] - EPS of $2.22 compared to consensus estimate of $2.15, leading to an EPS surprise of +3.26% [1] Key Metrics - Merck's stock has returned -10.6% over the past month, underperforming the Zacks S&P 500 composite's -5.1% change [3] - Current Zacks Rank for Merck is 3 (Hold), indicating potential performance in line with the broader market [3] Oncology Sales - Keytruda U.S. sales were $4.31 billion, below the average estimate of $4.47 billion, but up 4.6% year-over-year [4] - Keytruda International sales were $2.90 billion, compared to the $3.08 billion estimate, reflecting a 2.4% year-over-year increase [4] - Lynparza U.S. sales reached $145 million, exceeding the $121.96 million estimate, with a year-over-year increase of 7.4% [4] - Lynparza International sales were $168 million, below the $178.66 million estimate, but up 7% year-over-year [4] - Total Keytruda sales amounted to $7.21 billion, compared to the $7.55 billion estimate, marking a 3.7% year-over-year increase [4] Other Product Sales - Zerbaxa sales in Hospital Acute Care were $70 million, surpassing the $63.07 million estimate, with a 25% year-over-year increase [4] - Animal health sales were $1.59 billion, slightly below the $1.61 billion estimate, but up 5.1% year-over-year [4] - Prevymis sales were $208 million, exceeding the $190.69 million estimate, with a significant year-over-year increase of 19.5% [4] - Reblozyl sales reached $119 million, above the $101.77 million estimate, reflecting a substantial year-over-year increase of 67.6% [4]

Core Insights - Interpublic Group (IPG) reported a revenue of $2 billion for the quarter ended March 2025, reflecting an 8.6% decline year-over-year, with EPS at $0.33 compared to $0.36 in the same quarter last year [1] - The reported revenue matched the Zacks Consensus Estimate of $2 billion, resulting in a surprise of -0.28%, while the EPS exceeded the consensus estimate of $0.30 by 10% [1] Revenue Breakdown - International revenue before billable expenses was $638.10 million, below the average estimate of $672.67 million, marking a year-over-year decline of 9.7% [4] - Domestic revenue before billable expenses in the United States was $1.36 billion, slightly below the $1.37 billion estimate, representing an 8% decrease year-over-year [4] - Revenue before billable expenses in the Asia Pacific region was $119.30 million, significantly lower than the estimated $141.97 million, showing a 16.5% decline from the previous year [4] - Revenue before billable expenses in Continental Europe was $169.30 million, compared to the estimate of $174.82 million, indicating a 5.7% year-over-year decrease [4] - The United Kingdom's revenue before billable expenses was $159.40 million, below the estimated $170.75 million, reflecting a 10.5% decline year-over-year [4] - Latin America reported revenue before billable expenses of $72.50 million, under the average estimate of $90.28 million, representing a 16.8% decrease from the previous year [4] Stock Performance - Interpublic's shares have returned -9.4% over the past month, underperforming the Zacks S&P 500 composite, which saw a -5.1% change [3] - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the broader market in the near term [3]

Core Insights - First American Financial Corporation (FAF) reported first-quarter 2025 operating income per share of 84 cents, exceeding the Zacks Consensus Estimate by 29.2% and showing an 86.7% year-over-year increase [1] - Operating revenues reached $1.5 billion, an 11% increase year over year, driven by higher direct premiums, escrow fees, and net investment income, surpassing the Zacks Consensus Estimate by 3.2% [1][2] Financial Performance - Investment income for the first quarter was $135.2 million, a 5.7% year-over-year increase, but below the estimate of $142.2 million [2] - Total expenses rose 8.7% to $1.5 billion, aligning with estimates [2] - Adjusted pretax margin expanded by 310 basis points to 7.9% [4] Segment Results - Title Insurance and Services segment saw total revenues increase by 12% year over year to $1.5 billion, with investment income rising 18% to $137.7 million, primarily due to higher interest income [3] - Home Warranty segment revenues grew 2.5% to $107.8 million, with pretax income jumping 22% year over year [5] Corporate Financials - First American ended the quarter with cash and cash equivalents of $2 billion, a 19% increase from the end of 2024 [8] - Stockholders' equity rose to $5 billion, up 2.2% from the previous year [8] - The company reported a net investment income loss of $3.3 million, attributed to investment value fluctuations [6] Capital Deployment - FAF repurchased shares worth $28 million in the first quarter of 2025 and an additional $19 million through April 23 in the second quarter [10]

Pharmaceutical giant Merck & Co Inc (NYSE:MRK) has reversed its premarket lead, down 2% at $77.20 at last glance. The company posted better-than-expected first-quarter results but cut its profit outlook, expecting a $200 million dent from tariffs. Creeping back down toward its April 16 three-year low of $75.95, MRK is down 22.7% since the start of the year. So far today, MRK has seen 21,000 calls and 29,000 puts exchanged -- triple the overall options volume typically seen at this point. The May 75 put is t ...